What the evidence says
How to read these marks1 finding · 1 endpoint · 1 paper · by evidence strength
What moved
1 finding
Increases plasma glucagon-like peptide-1 (GLP-1)
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Arterial plasma concentrations of total GLP‐1 increased during glucose + NaCl and glucose alone, however, an apparent plateau (incremental AUC, lasting from 40–80 min) was significantly higher during glucose + NaCl compared with glucose alone.”
Quoted verbatim from Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP-1 but not GIP, CCK, and gastrin in plasma.. - Study
- crossover
- Dose
- 6 g (103 mmol) NaCl single oral dose dissolved with 75 g glucose in 500 mL tap water
- Population
- Healthy young men; 6 g oral NaCl added to a 75 g oral glucose load versus the glucose load alone, after a standardised 4-day sodium intake; arterial blood sampling
Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP-1 but not GIP, CCK, and gastrin in plasma.2020PMID:32770661Permalink
Papers screened
197 papers
- Compound
- sodium chloride
- Screened
- 197
- Admitted
- 1
- Discarded
- 91
- Not read
- 105
Produced a finding1 paper
- PMID:327706612026-10-05
Discarded: the wrong intervention71 papers
- PMID:34038318no claim extracted — reagent_not_exposure2026-10-05
- NCT00224484intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00248040intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00353119intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00381615intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00429702intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00575016intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00604695intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00653432intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00676585intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00735839intervention×1 — no declared intervention names sodium chloride2026-09-29
- NCT00758485intervention×1 — no declared intervention names sodium chloride2026-09-29
and 59 more.
Discarded: another reason, stated per paper8 papers
- PMID:1531430no claim extracted — cause not determined — DOSED: rice-based oral rehydration salts solution versus glucose-based WHO oral rehydration salts solution, abstract; sodium chloride is never named2026-10-05
- PMID:34378307no claim extracted — subject_absent — DOSED: regular human insulin (Myxredlin BAX-HI 1 U/mL in 0.9% NaCl vs Novolin R diluted to 1 U/mL in 0.9% NaCl), IV, Methods 2.1 | regular human insulin: BAX-HI (Myxredlin, 1 U/mL in 0.9% sodium chloride) versus NOVO-HI (Novolin R diluted to 1 U/mL in 0.9% sodium chloride), Methods; sodium chloride is the diluent in both arms, not the tested exposure2026-10-05
- PMID:35970918no claim extracted — cause not determined (one pass only) — measured: rate of stable intracavitary ECG derivation / characteristic P wave occurrence during ECG-guided catheter tip localization, chi-squared; time to catheter tip localization in seconds2026-10-05
- NCT00321685design×1 — allocation NA -- not randomised2026-09-29
- NCT03008707design×1 — studyType OBSERVATIONAL -- only INTERVENTIONAL is extracted2026-09-29
- NCT03442556design×1 — allocation NA -- not randomised2026-09-29
- NCT05177328design×1 — allocation NA -- not randomised2026-09-29
- NCT05502081design×1 — allocation NON_RANDOMIZED -- not randomised2026-09-29
Discarded: no extractable result7 papers
- PMID:23110412no claim extracted — no_quantitative_result2026-10-05
- PMID:40455066claims extracted but the two passes did not agree2026-10-05
- NCT01680328declared_contrast×6 — no posted analysis compares a sodium chloride arm with a placebo/no-intervention arm and carries a p-value (Thighs: Injection Region-5 s.c Injections+1 Needle Insertion=unmatched, Abdomen: Injection Region-12 s.c Injections+1 Needle Insertion=unmatched, Injection Volume 1600 μL=unmatched, Injection2026-09-29
- NCT02233985declared_contrast×2, reporting_status×2 — no posted analysis compares a sodium chloride arm with a placebo/no-intervention arm and carries a p-value (Hypertonic Saline Solution 3% (HSS 3%) Group=unmatched, Saline Solution 0.9% (SS 0.9%) Group=unmatched)2026-09-29
- NCT02421419declared_contrast×4 — no posted analysis compares a sodium chloride arm with a placebo/no-intervention arm and carries a p-value (Corticosteroid Alone (CS) Group=ACTIVE_COMPARATOR, Corticosteroid/Lidocaine (CSL) Group=ACTIVE_COMPARATOR, Corticosteroid/Saline (CSS) Group=ACTIVE_COMPARATOR+subject)2026-09-29
- NCT03007537declared_contrast×2 — no posted analysis compares a sodium chloride arm with a placebo/no-intervention arm and carries a p-value (Control Group=PLACEBO_COMPARATOR+subject, Erythropoietin Group=EXPERIMENTAL)2026-09-29
- NCT04847141outcome_node×8, declared_contrast×7, multiple_analyses×5, commit×2 — 2 analyses of the same contrast (ANCOVA p=0.5756; ANCOVA p=0.3418) -- the record does not declare which is primary2026-09-29
Discarded: no comparator4 papers
- PMID:27480410no claim extracted — comparator_not_absence2026-10-05
- PMID:30058070no claim extracted — comparator_not_absence2026-10-05
- PMID:32352563no claim extracted — comparator_not_absence2026-10-05
- PMID:35849083no claim extracted — comparator_not_absence2026-10-05
Discarded: an endpoint this vocabulary does not hold1 paper
- PMID:24308613no claim extracted — endpoint_near_miss — measured: emergency department length of stay, triage to ED discharge in minutes (hospital-length-of-stay node is admission to hospital discharge) | emergency department length of stay, minutes from triage to ED discharge (the hospital-length-of-stay node covers admission to hospital discharge)2026-10-05
Not read yet105 papers
- PMID:213316502026-10-04
- PMID:100749172026-10-04
- PMID:89701842026-10-04
- PMID:117522402026-10-03
- PMID:114517822026-09-29
- PMID:25022512026-09-29
- PMID:90383462026-09-29
- PMID:155300662026-09-29
- PMID:92683212026-09-29
- PMID:104146722026-09-29
- PMID:105228532026-09-29
- PMID:106019172026-09-29
and 93 more.
Measured, not recorded
- Compound
- sodium chloride
- Endpoints measured
- 262 endpoints
- Recorded as a finding
- No
Show what was measured
Rate of stool loss
decreases
The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only 18% (6 to 30%)
PMID:1531430 · one of two readings recorded this
Rate of stool output during first 24 hours
decreases
by 36% (95% confidence interval 28 to 44%) in adults with cholera
PMID:1531430 · one of two readings recorded this
Rate of stool output during first 24 hours
decreases
by 32% (19 to 45%) in children with cholera
PMID:1531430 · one of two readings recorded this
infarct responsible focuses in MCA territory by MRI, preliminary study
n = 25
According to our preliminary study, 60% (15/25) of patients were found infarct responsible focuses in MCA territory by MRI brain scanning
PMID:23110412 · one of two readings recorded this
TTP (time to peak, CT perfusion) mean difference after HES 130/0.4, preliminary data used for sample size
The mean difference and standard deviation of TTP after HES 130/0.4 were 19.83 and 10.21, respectively
PMID:23110412 · one of two readings recorded this
Absolute change of breath alcohol level (BAL)
no effect, p = 0.16
Absolute change of BAL at 2 h | −0.036 (0.03) | −0.013 (0.1) | −0.023 (−0.06 to 0.01) | 0.16
PMID:24308613 · one of two readings recorded this
Absolute change of breath alcohol level, sentence statement
no effect, p = 0.16
−0.036 mg/L BrAC and −0.013 mg/L BrAC, P = 0.16
PMID:24308613 · one of two readings recorded this
Absolute change of total OAAI score
no effect, p = 0.16
Absolute change of total OAAI score at 2 h | −10 (9) | −7 (8) | −3 (−6 to 1) | 0.16
PMID:24308613 · one of two readings recorded this
baseline age
Age (years) | 24.9 (8.4) (n = 73) | 24.3 (7.4) (n = 71)
PMID:24308613 · one of two readings recorded this
baseline blood alcohol content
Blood alcohol content (%) | 0.195 (0.07) (n = 59) | 0.185 (0.63) (n = 53)
PMID:24308613 · one of two readings recorded this
baseline breath alcohol level
Breath alcohol level (%) | 0.167 (0.07) (n = 56) | 0.172 (0.06) (n = 58)
PMID:24308613 · one of two readings recorded this
baseline height
Height (cm) | 171.5 (8.6) (n = 62) | 171.0 (10.7) (n = 58)
PMID:24308613 · one of two readings recorded this
baseline intake of other drugs, n (%)
Intake of other drugs (%) | 48/73 (66) | 46/71 (65)
PMID:24308613 · one of two readings recorded this
baseline intoxication score (OAAI) at initial presentation
Intoxication score at initial presentation (OAAI) | 22.1 (10.5) (n = 71) | 22.3 (9.6) (n = 68)
PMID:24308613 · one of two readings recorded this
baseline male participants, n (%)
No. (%) male | 39/73 (53) | 42/71 (59)
PMID:24308613 · one of two readings recorded this
baseline standard drinks consumed
Standard drinks consumed | 11.1 (6.6) (n = 44) | 10.8 (3.8) (n = 38)
PMID:24308613 · one of two readings recorded this
baseline weight
Weight (kg) | 70.2 (14.3) (n = 72) | 70.7 (13.8) (n = 64)
PMID:24308613 · one of two readings recorded this
ED length of stay (EDLOS), primary end-point
no effect, p = 0.89
EDLOS | 287 (171) | 274 (131) | 14 (−37 to 63) | 0.89
PMID:24308613 · one of two readings recorded this
EDLOS mean, sentence statement
no effect
Patients treated with i.v. normal saline had an EDLOS of 287 min compared with those observed alone who had an EDLOS of 274 min
PMID:24308613 · one of two readings recorded this
EDLOS treatment difference, sentence statement
no effect, p = 0.89
There was no significant difference found between the two groups (difference of 14 min, 95% CI −37 to 63 min, P = 0.89)
PMID:24308613 · one of two readings recorded this
emergency department length of stay (EDLOS), defined from triage time to actual discharge time from the ED, IV 20 mL/kg 0.9% NaCl plus observation versus observation alone
no effect, difference of 14 min, 95% CI −37 to 63 min, p = 0.89
Not recorded as a finding: a node exists but the paper states a different instrument or population
There was no significant difference found between the two groups (difference of 14 min, 95% CI −37 to 63 min, P = 0.89).
PMID:24308613 · one of two readings recorded this
emergency department length of stay (EDLOS), from triage time to actual ED discharge, minutes; single 20 mL/kg i.v. 0.9% NaCl plus observation versus observation alone, alcohol-intoxicated adults
no effect, difference of 14 min, 95% CI -37 to 63 min, p = 0.89
Not recorded as a finding: a node exists but the paper states a different instrument or population
There was no significant difference found between the two groups (difference of 14 min, 95% CI −37 to 63 min, P = 0.89).
PMID:24308613 · one of two readings recorded this
General state of intoxication (change in level)
no effect, p = 0.82
There was no perceived change in general state of intoxication at 2 h between the two groups (P = 0.82)
PMID:24308613 · one of two readings recorded this
Healthcare cost: medical staff
increases
Medical (+ night differential) | 48.72 | 0.43 | 21.11 | 0.86 | 41.95
PMID:24308613 · one of two readings recorded this
Healthcare cost: nursing staff
increases
Nursing (+ night differential) | 45.28 | 1.04 | 47.25 | 1.12 | 50.83
PMID:24308613 · one of two readings recorded this
Healthcare cost: subtotal material
increases
Subtotal material | 4.30 | 11.80
PMID:24308613 · one of two readings recorded this
Healthcare cost: subtotal staff
increases
Subtotal staff | 68.36 | 92.78
PMID:24308613 · one of two readings recorded this
Healthcare cost: subtotal tests
no effect
Subtotal tests | 51.14 | 51.14
PMID:24308613 · one of two readings recorded this
Healthcare resource cost, difference treatment minus control
increases
Comparing the costs of resources used, the treatment group used A$31.92 more
PMID:24308613 · one of two readings recorded this
Healthcare resource cost per patient
increases
Grand total | 124.52 | 156.44
PMID:24308613 · one of two readings recorded this
Per cent change of BAL
no effect, p = 0.74
Per cent change of BAL at 2 h | −19 (14) | −8 (69) | −11 (−33 to 10) | 0.74
PMID:24308613 · one of two readings recorded this
Per cent change of total OAAI score
no effect, p = 0.34
Per cent change of total OAAI score at 2 h | −40 (33) | −33 (44) | −7 (−21 to 7) | 0.34
PMID:24308613 · one of two readings recorded this
Rate of change of BAL
no effect, p = 0.82
Rate of change (%/h) of BAL at discharge | −0.01 (0.04) | −0.02 (0.02) | 0.01 (−0.01 to 0.03) | 0.82
PMID:24308613 · one of two readings recorded this
Rate of change of BAL
no effect, p = 0.16
Rate of change (%/h) of BAL at 2 h | −0.02 (0.01) | −0.01 (0.05) | −0.01 (−0.03 to 0.01) | 0.16
PMID:24308613 · one of two readings recorded this
Rate of change of total OAAI score
no effect, p = 0.31
Rate of change of total OAAI score (points/h) at discharge | −3.6 (3.0) | −4.2 (3.0) | 0.6 (−0.6 to 2.4) | 0.31
PMID:24308613 · one of two readings recorded this
Rate of change of total OAAI score
no effect, p = 0.16
Rate of change of total OAAI score (points/h) at 2 h | −4.8 (4.8) | −3.6 (4.2) | −1.2 (−3.0 to 0.6) | 0.16
PMID:24308613 · one of two readings recorded this
Treatment time mean, sentence statement
no effect, p = 0.94
treatment time, was similar between treatment and control (244 min vs 232 min, P = 0.94)
PMID:24308613 · one of two readings recorded this
Treatment time
no effect, p = 0.94
Treatment time | 244 (143) | 232 (116) | 12 (−31 to 55) | 0.94
PMID:24308613 · one of two readings recorded this
BARF scale at hour 2
no effect, p = 0.55, n = 77
Hour 2 | 1.5 ± 3.10 | 2.00 ± 2.58 |.55
PMID:27480410 · one of two readings recorded this
BARF scale at hour 4
no effect, p = 0.12, n = 77
Hour 4 | 0.3 ± 0.98 | 1.23 ± 2.24 |.12
PMID:27480410 · one of two readings recorded this
BARF scale, baseline value (row also prints between-group P)
no effect, p = 0.27, n = 77
Baseline (Hour 0) | 5.10 ± 4.02 | 4.43 ± 3.86 |.27
PMID:27480410 · one of two readings recorded this
BARF score change from baseline at hour 2 (0.9 % NaCl)
no effect, p = 0.08
Patients in the 0.9 % NaCl group did not show similar BARF score improvements at hour 2 (mean change−2.1 ± 4.0; P =.08) but did at hour 4 (mean change −2.9 ± 3.88; P =.02)
PMID:27480410 · one of two readings recorded this
BARF score change from baseline at hour 2 (Plasma-Lyte A)
decreases, p = 0.005
Patients in the PLA group had improvement in BARF scores from baseline to hour 2 (mean change −3.6 ± 5.1; P =.005) and hour 4 (mean change −4.8 ± 3.97; P =.005)
PMID:27480410 · one of two readings recorded this
BARF score change from baseline at hour 4 (0.9 % NaCl)
decreases, p = 0.02
Patients in the 0.9 % NaCl group did not show similar BARF score improvements at hour 2 (mean change−2.1 ± 4.0; P =.08) but did at hour 4 (mean change −2.9 ± 3.88; P =.02)
PMID:27480410 · one of two readings recorded this
BARF score change from baseline at hour 4 (Plasma-Lyte A)
decreases, p = 0.005
Patients in the PLA group had improvement in BARF scores from baseline to hour 2 (mean change −3.6 ± 5.1; P =.005) and hour 4 (mean change −4.8 ± 3.97; P =.005)
PMID:27480410 · one of two readings recorded this
baseline age (months, mean)
n = 77
Age*, months, mean | 45.9 | 34.2
PMID:27480410 · one of two readings recorded this
baseline BUN
n = 77
BUN, mg/dL | 16.5 ± 7.17 | 14.6 ± 6.33
PMID:27480410 · one of two readings recorded this
baseline capillary refill time
n = 77
Capillary refill time*, seconds | 3.3 ± 0.50 | 2.8 ± 0.26
PMID:27480410 · one of two readings recorded this
baseline creatinine
n = 77
Creatinine*, mg/dL | 0.43 ± 0.13 | 0.37 ± 0.10
PMID:27480410 · one of two readings recorded this
baseline diarrhea episodes
n = 77
Diarrhea episodes | 4.8 ± 4.77 | 6.8 ± 6.77
PMID:27480410 · one of two readings recorded this
baseline glucose
n = 77
Glucose, mg/dL | 70.3 ± 21.26 | 74.4 ± 21.62
PMID:27480410 · one of two readings recorded this
baseline serum chloride
n = 77
Chloride, mEq/L | 103.0 ± 4.74 | 103.5 ± 4.19
PMID:27480410 · one of two readings recorded this
baseline serum potassium
n = 77
Potassium, mEq/L | 4.4 ± 0.80 | 4.2 ± 0.67
PMID:27480410 · one of two readings recorded this
baseline serum sodium
n = 77
Sodium, mEq/L | 137.0 ± 4.07 | 136.9 ± 2.93
PMID:27480410 · one of two readings recorded this
baseline vomiting episodes
n = 77
Vomiting episodes | 8.9 ± 8.53 | 6.1 ± 5.92
PMID:27480410 · one of two readings recorded this
baseline weight
n = 77
Weight*, kg | 15.8 ± 5.18 | 13.5 ± 6.80
PMID:27480410 · one of two readings recorded this
change in venous serum bicarbonate (total carbon dioxide) from baseline to hour 4, primary outcome, Plasma-Lyte A versus 0.9% sodium chloride in children with gastroenteritis
Not recorded as a finding: the comparison was against another active treatment
Patients receiving PLA demonstrated significantly greater increase in serum bicarbonate levels from baseline to hour 4 compared with patients receiving 0.9 % NaCl.
PMID:27480410 · one of two readings recorded this
duration of fluid administration
no effect
duration of administration was 104.3 min vs 93.7 min
PMID:27480410 · one of two readings recorded this
FACES pain scale at hour 2
no effect, n = 77
Hour 2 | 1.1 ± 1.55 | 1.9 ± 1.60
PMID:27480410 · one of two readings recorded this
FACES pain scale at hour 4
no effect, n = 77
Hour 4 | 0.37 ± 0.60 | 1.11 ± 1.54 | NA
PMID:27480410 · one of two readings recorded this
FACES pain scale, baseline value (row also prints between-group P)
no effect, p = 0.31, n = 77
Baseline (Hour 0) | 2.3 ± 1.86 | 3.2 ± 1.90 |.31
PMID:27480410 · one of two readings recorded this
FLACC pain scale at hour 2
decreases, n = 77
Hour 2 | 0.6 ± 0.98 | 1.7 ± 2.59
PMID:27480410 · one of two readings recorded this
FLACC pain scale at hour 4
no effect, p = 0.15, n = 77
Hour 4 | 1.44 ± 2.18 | 0.68 ± 1.35 |.15
PMID:27480410 · one of two readings recorded this
FLACC pain scale, baseline value (row also prints between-group P)
decreases, p = 0.03, n = 77
Baseline (Hour 0) | 2.0 ± 1.91 | 1.7 ± 2.00 |.03
PMID:27480410 · one of two readings recorded this
Gorelick dehydration scale at hour 2
decreases, n = 77
Hour 2 | 2.0 ± 1.45 | 2.8 ± 1.74
PMID:27480410 · one of two readings recorded this
Gorelick dehydration scale at hour 4
no effect, p = 0.08, n = 77
Hour 4 | 0.81 ± 0.84 | 1.41 ± 1.08 |.08
PMID:27480410 · one of two readings recorded this
Gorelick dehydration scale, baseline value (row also prints between-group P)
decreases, p = 0.03, n = 77
Baseline (hour 0) | 5.2 ± 0.93 | 5.3 ± 1.11 |.03
PMID:27480410 · one of two readings recorded this
Hospitalized, n (%)
no effect, p = 0.86, n = 77
Hospitalized, n (%) | 12 (31) | 11 (29) |.86
PMID:27480410 · one of two readings recorded this
maintenance fluid volume
no effect
maintenance fluid was 12.2 vs 12.3 mL/kg PLA vs 0.9 % NaCl respectively
PMID:27480410 · one of two readings recorded this
number of study boluses
no effect
The number of boluses was 1.9 for both groups
PMID:27480410 · one of two readings recorded this
pre-study fluid administered before study fluid
no effect
PLA: 17.98 ± 11.17 ml/kg vs 0.9 % NaCl: 15.38 ± 6.55 ml/kg
PMID:27480410 · one of two readings recorded this
serum bicarbonate, age stratum
increases, p = 0.05
Comparison by age strata demonstrated PLA superiority for the >2 years to ≤5 years age range (mean 17.16 to 18.31; P <.05)
PMID:27480410 · one of two readings recorded this
serum bicarbonate at hour 4
increases, n = 77
Hour 4 | 18.5 ± 3.74 | 18.0 ± 3.67
PMID:27480410 · one of two readings recorded this
serum bicarbonate at hour 4
increases, n = 23
Hour 4 (n) | 16.1 ± 2.28 (12) | 14.7 ± 2.90 (11)
PMID:27480410 · one of two readings recorded this
serum bicarbonate at hour 4
no effect, n = 46
Hour 4 (n) | 20.35 ± 3.18 (22) | 19.53 ± 2.95 (24)
PMID:27480410 · one of two readings recorded this
serum bicarbonate at hour 4
increases, n = 3
Hour 4 (n) | 14.3 ± 4.16 (3) | – (0)
PMID:27480410 · one of two readings recorded this
serum bicarbonate, baseline value (row also prints between-group P for change to hour 4)
increases, p = 0.004, n = 77
Baseline (hour 0) | 16.9 ± 3.51 | 17.8 ± 2.82 |.004
PMID:27480410 · one of two readings recorded this
serum bicarbonate, baseline value (row also prints between-group P)
increases, p = 0.04, n = 26
Baseline (hour 0) (n) | 14.5 ± 1.34 (13) | 14.6 ± 1.29 (13) |.04
PMID:27480410 · one of two readings recorded this
serum bicarbonate, baseline value (row also prints between-group P)
no effect, p = 0.11, n = 48
Baseline (hour 0) (n) | 19.23 ± 1.86 (23) | 19.51 ± 1.68 (25) |.11
PMID:27480410 · one of two readings recorded this
serum bicarbonate, baseline value (severe acidosis stratum)
n = 3
Baseline (hour 0) (n) | 9.3 ± 0.58 (3) | – (0) | NAb
PMID:27480410 · one of two readings recorded this
serum bicarbonate change, PLA-treated severe acidosis patients
increases
The three patients with severe acidosis who received PLA demonstrated a mean improvement in serum bicarbonate level from 9.3 ± 0.6 mEq/L to 14.3 ± 4.2 mEq/L
PMID:27480410 · one of two readings recorded this
serum chloride at hour 4
increases, n = 77
Hour 4 | 104.49 ± 3.18 | 108.51 ± 4.87
PMID:27480410 · one of two readings recorded this
serum chloride, baseline value (row also prints between-group P)
increases, p = 0.001, n = 77
Baseline | 103.03 ± 4.74 | 103.53 ± 4.19 | <0.001
PMID:27480410 · one of two readings recorded this
study treatment dose (mL/kg)
no effect
dose of study treatment was 38.4 mL/kg vs 39.6 mL/kg
PMID:27480410 · one of two readings recorded this
Time to rehydration
no effect, p = 0.13, n = 77
Time to Rehydrationa, h | 6.1 ± 1.75 | 7.0 ± 2.7 |.13
PMID:27480410 · one of two readings recorded this
CVC occlusion (all occlusions)
decreases, p = 0.02, n = 1672
risk ratio (RR) 0.70, 95% confidence interval (CI) 0.51 to 0.95; P = 0.02; 1672 participants; 1025 catheters from 10 studies; I² = 14%
PMID:30058070 · one of two readings recorded this
CVC occlusion (all occlusions)
no effect, p = 0.23
testing for subgroup differences (P = 0.23; I² = 30.3%)
PMID:30058070 · one of two readings recorded this
CVC occlusion (all occlusions)
decreases, p = 0.03, n = 1025
RR 0.53, 95% CI 0.29 to 0.95; P = 0.03; 1025 catheters; three studies
PMID:30058070 · one of two readings recorded this
CVC occlusion (all occlusions)
no effect, n = 770
RR 1.08, 95% CI 0.84 to 1.40; 770 line accesses; one study
PMID:30058070 · one of two readings recorded this
CVC occlusion (all occlusions)
no effect, p = 0.15, n = 1672
RR 0.79, 95% CI 0.58 to 1.08; P = 0.15; 1672 participants; seven studies
PMID:30058070 · one of two readings recorded this
CVC-related sepsis
no effect, p = 0.86, n = 1097
RR 0.74, 95% CI 0.03 to 19.54; P = 0.86; 1097 participants
PMID:30058070 · one of two readings recorded this
Duration of catheter patency
no effect, p = 0.11, n = 1036
mean difference (MD) 0.44 days, 95% CI -0.10 to 0.99; P = 0.11; 1036 participants; 752 catheters; six studies; low-quality evidence
PMID:30058070 · one of two readings recorded this
Haemorrhage at any site
no effect, p = 0.52, n = 1245
RR 1.32, 95% CI 0.57 to 3.07; P = 0.52; 1245 participants
PMID:30058070 · one of two readings recorded this
Heparin-induced thrombocytopaenia
no effect, p = 0.31, n = 443
RR 0.21, 95% CI 0.01 to 4.27; P = 0.31; 443 participants
PMID:30058070 · one of two readings recorded this
Mortality
no effect, p = 0.33, n = 1100
RR 0.76, 95% CI 0.44 to 1.31; P = 0.33; 1100 participants
PMID:30058070 · one of two readings recorded this
occlusion of central venous catheters, pooled risk ratio, heparin versus 0.9% NaCl locking in adults
RR 0.70, 95% CI 0.51 to 0.95 for occlusion with heparin versus NS, p = 0.02
Not recorded as a finding: the comparison was against another active treatment
Combined results from these studies showed fewer occlusions with heparin than with NS (risk ratio (RR) 0.70, 95% confidence interval (CI) 0.51 to 0.95; P = 0.02; 1672 participants; 1025 catheters from 10 studies; I² = 14%) and provided very low-quality evidence.
PMID:30058070 · one of two readings recorded this
CVC-associated blood stream infection
no effect, n = 231
The estimated RR for CVC-associated blood stream infection was 1.48 (95% CI 0.24 to 9.37; 2 studies, 231 participants; low-certainty evidence)
PMID:32352563 · one of two readings recorded this
CVC occlusion per 1000 catheter days
no effect, n = 229
was 0.75 (95% CI 0.10 to 5.51; 2 studies, 229 participants; very low certainty evidence)
PMID:32352563 · one of two readings recorded this
Duration of catheter placement
no effect, n = 203
The duration of catheter placement was reported to be similar for the two study arms in one study (203 participants; moderate-certainty evidence)
PMID:32352563 · one of two readings recorded this
occlusion of long-term central venous catheters per 1000 catheter days, normal saline versus heparin flushing, in infants and children
RR 0.75 (95% CI 0.10 to 5.51) for saline versus heparin, very low certainty
Not recorded as a finding: the comparison was against another active treatment
The estimated RR for CVC occlusion per 1000 catheter days between the normal saline and heparin groups was 0.75 (95% CI 0.10 to 5.51; 2 studies, 229 participants; very low certainty evidence).
PMID:32352563 · one of two readings recorded this
24-hr urinary potassium excretion at baseline
no effect, p = 0.986, n = 10
Potassium (mmol/24‐hr) | 60 ± 6 | 59 ± 6 |.986
PMID:32770661 · one of two readings recorded this
24-hr urinary sodium excretion at baseline
no effect, p = 0.879, n = 10
Sodium (mmol/24‐hr) | 133 ± 11 | 132 ± 11 |.879
PMID:32770661 · one of two readings recorded this
24-hr urine collection time before study day
no effect, p = 0.575, n = 10
all 24‐hr urine collections were successfully completed with similar mean collection time on each study day (23.8 ± 0.6 hr versus 23.3 ± 0.3 hr, p =.575)
PMID:32770661 · one of two readings recorded this
24-hr urine pH at baseline
no effect, p = 0.439, n = 10
pH | 5.9 ± 0.1 | 5.8 ± 0.1 |.439
PMID:32770661 · one of two readings recorded this
24-hr urine volume at baseline
no effect, p = 0.451, n = 10
Volume (mL/24‐hr) | 1,560 ± 200 | 1,628 ± 212 |.451
PMID:32770661 · one of two readings recorded this
arterial angiotensin II (RIA), after oral glucose load with or without NaCl
decreases, significantly lower from 60-80 min incremental AUC during glucose + NaCl
Not recorded as a finding: no outcome node for angiotensin II
Arterial plasma concentrations of ANG II were significantly lower from 60–80 min (incremental AUC) during glucose + NaCl compared with glucose alone.
PMID:32770661 · one of two readings recorded this
arterial plasma angiotensin II (incremental AUC)
decreases, n = 10
Arterial plasma concentrations of ANG II were significantly lower from 60–80 min (incremental AUC) during glucose + NaCl compared with glucose alone
PMID:32770661 · one of two readings recorded this
arterial plasma angiotensin II, RIA, incremental AUC 60-80 min
decreases, significantly lower from 60-80 min during glucose + NaCl compared with glucose alone
Not recorded as a finding: no outcome node for angiotensin II
Arterial plasma concentrations of ANG II were significantly lower from 60–80 min (incremental AUC) during glucose + NaCl compared with glucose alone.
PMID:32770661 · one of two readings recorded this
arterial plasma calcium and hematocrit
no effect, n = 10
Plasma concentrations of calcium, and hematocrit remained unchanged during glucose + NaCl compared with glucose alone
PMID:32770661 · one of two readings recorded this
arterial plasma CCK and gastrin
no effect, n = 10
Arterial plasma concentrations of CCK and gastrin increased on both days and no statistically significant differences between the days were observed
PMID:32770661 · one of two readings recorded this
arterial plasma CCK, radioimmunoassay, postprandial after oral glucose load
no effect, no statistically significant differences between the days
Not recorded as a finding: plasma-cholecystokinin node exists but the only sentence is agentless and never names NaCl (rule 1)
Arterial plasma concentrations of CCK and gastrin increased on both days and no statistically significant differences between the days were observed.
PMID:32770661 · one of two readings recorded this
arterial plasma chloride and hydrogen
increases, n = 10
Plasma concentrations of chloride and hydrogen only increased significantly during glucose + NaCl
PMID:32770661 · one of two readings recorded this
arterial plasma GIP, immunoassay, postprandial after oral glucose load
no effect, no statistically significant differences between the days
Not recorded as a finding: plasma-gip node exists but the only sentence is agentless and never names NaCl (rule 1)
Arterial plasma concentrations of GIP increased on both days and no statistically significant differences between the days were observed.
PMID:32770661 · one of two readings recorded this
arterial plasma GIP
no effect, n = 10
Arterial plasma concentrations of GIP increased on both days and no statistically significant differences between the days were observed
PMID:32770661 · one of two readings recorded this
arterial plasma glucose, insulin and C-peptide
no effect, n = 10
Arterial plasma concentrations of glucose, insulin, and C‐peptide increased similarly during glucose + NaCl and glucose alone
PMID:32770661 · one of two readings recorded this
arterial plasma potassium
no effect, n = 10
Plasma potassium concentrations decreased similarly during during glucose + NaCl and glucose alone
PMID:32770661 · one of two readings recorded this
arterial plasma proANP, ANP and BNP
no effect, n = 10
Arterial plasma concentrations of proANP, ANP, and BNP remained unchanged on both days and no statistically significant differences between the days were observed
PMID:32770661 · one of two readings recorded this
arterial plasma renin and aldosterone
no effect, n = 10
Arterial plasma concentrations of renin and aldosterone remained unchanged on both days and no significant differences between the days were observed (respectively)
PMID:32770661 · one of two readings recorded this
arterial plasma sodium
increases, n = 10
Arterial plasma concentrations of sodium increased during glucose + NaCl and glucose alone compared to baseline, however, the increase was significantly higher during glucose + NaCl compared with glucose
PMID:32770661 · one of two readings recorded this
arterial plasma total GLP-1 (incremental AUC plateau)
increases, n = 10
Arterial plasma concentrations of total GLP‐1 increased during glucose + NaCl and glucose alone, however, an apparent plateau (incremental AUC, lasting from 40–80 min) was significantly higher during glucose + NaCl compared with glucose alone
PMID:32770661 · one of two readings recorded this
plasma cholecystokinin (CCK, radioimmunoassay) and gastrin after oral glucose load with or without NaCl
no effect, no statistically significant differences between the days
Not recorded as a finding: plasma-cholecystokinin node exists, but the only sentence names 'both days' not the compound, so it is not self-supporting (quote_not_self_supporting); gastrin has no node
Arterial plasma concentrations of CCK and gastrin increased on both days and no statistically significant differences between the days were observed.
PMID:32770661 · one of two readings recorded this
plasma glucose-dependent insulinotropic polypeptide (GIP), immunoassay, after oral glucose load with or without NaCl
no effect, no statistically significant differences between the days
Not recorded as a finding: plasma-glp-1 sibling node plasma-gip exists, but the only sentence is not self-supporting: it names 'the days', never NaCl or glucose + NaCl (quote_not_self_supporting)
Arterial plasma concentrations of GIP increased on both days and no statistically significant differences between the days were observed.
PMID:32770661 · one of two readings recorded this
Aerosol charge
Corn oil aerosol, however, at near neutral charge (~ +0.5 fA)
PMID:34038318 · one of two readings recorded this
Aerosol charge
NaCl aerosol was highly charged (~ +70 fA)
PMID:34038318 · one of two readings recorded this
Aerosol count median diameter
The smaller-sized NaCl aerosol (~80 nm count median diameter) may not have contributed to the larger TIL than corn oil aerosol had (~190 nm count median diameter)
PMID:34038318 · one of two readings recorded this
Aerosol count median diameter
The smaller-sized NaCl aerosol (~80 nm count median diameter) may not have contributed to the larger TIL than corn oil aerosol had (~190 nm count median diameter)
PMID:34038318 · one of two readings recorded this
Fit factor
Fit factors were ~1,600, ~6,200, and ~5,800 for EHRs, full-facepiece respirators, and tight-fitting PAPRs, which yielded GM TIL values of ~0.1%, ~0.03%, and ~0.006%, respectively
PMID:34038318 · one of two readings recorded this
Fit factor
Fit factors were ~1,600, ~6,200, and ~5,800 for EHRs, full-facepiece respirators, and tight-fitting PAPRs, which yielded GM TIL values of ~0.1%, ~0.03%, and ~0.006%, respectively
PMID:34038318 · one of two readings recorded this
Fit factor
Fit factors were ~1,600, ~6,200, and ~5,800 for EHRs, full-facepiece respirators, and tight-fitting PAPRs, which yielded GM TIL values of ~0.1%, ~0.03%, and ~0.006%, respectively
PMID:34038318 · one of two readings recorded this
GM TIL by respirator type
Fit factors were ~1,600, ~6,200, and ~5,800 for EHRs, full-facepiece respirators, and tight-fitting PAPRs, which yielded GM TIL values of ~0.1%, ~0.03%, and ~0.006%, respectively
PMID:34038318 · one of two readings recorded this
GM TIL by respirator type
Fit factors were ~1,600, ~6,200, and ~5,800 for EHRs, full-facepiece respirators, and tight-fitting PAPRs, which yielded GM TIL values of ~0.1%, ~0.03%, and ~0.006%, respectively
PMID:34038318 · one of two readings recorded this
GM TIL by respirator type
Fit factors were ~1,600, ~6,200, and ~5,800 for EHRs, full-facepiece respirators, and tight-fitting PAPRs, which yielded GM TIL values of ~0.1%, ~0.03%, and ~0.006%, respectively
PMID:34038318 · one of two readings recorded this
TIL of EHR models with N95 filters, previous study (model 1)
TIL for the same two EHR models equipped with N95 filters were 0.21 and 0.13 for NaCl aerosol and 0.73 and 1.09 for corn oil aerosol (ISO 2017)
PMID:34038318 · one of two readings recorded this
TIL of EHR models with N95 filters, previous study (model 1)
TIL for the same two EHR models equipped with N95 filters were 0.21 and 0.13 for NaCl aerosol and 0.73 and 1.09 for corn oil aerosol (ISO 2017)
PMID:34038318 · one of two readings recorded this
TIL of EHR models with N95 filters, previous study (model 2)
TIL for the same two EHR models equipped with N95 filters were 0.21 and 0.13 for NaCl aerosol and 0.73 and 1.09 for corn oil aerosol (ISO 2017)
PMID:34038318 · one of two readings recorded this
TIL of EHR models with N95 filters, previous study (model 2)
TIL for the same two EHR models equipped with N95 filters were 0.21 and 0.13 for NaCl aerosol and 0.73 and 1.09 for corn oil aerosol (ISO 2017)
PMID:34038318 · one of two readings recorded this
TIL of N95 filter material, previous study
The TIL values for P100 and N95 filter materials were 0.04 and 0.06 for NaCl aerosol and 0.09 and 0.19 for corn oil aerosol (Table 4)
PMID:34038318 · one of two readings recorded this
TIL of N95 filter material, previous study
The TIL values for P100 and N95 filter materials were 0.04 and 0.06 for NaCl aerosol and 0.09 and 0.19 for corn oil aerosol (Table 4)
PMID:34038318 · one of two readings recorded this
TIL of P100 filter material, previous study
The TIL values for P100 and N95 filter materials were 0.04 and 0.06 for NaCl aerosol and 0.09 and 0.19 for corn oil aerosol (Table 4)
PMID:34038318 · one of two readings recorded this
TIL of P100 filter material, previous study
The TIL values for P100 and N95 filter materials were 0.04 and 0.06 for NaCl aerosol and 0.09 and 0.19 for corn oil aerosol (Table 4)
PMID:34038318 · one of two readings recorded this
Total inward leakage (TIL), geometric mean, NaCl vs corn oil aerosol
decreases, p = 0.05, n = 16
The two EHR models with P100 filters showed significantly (p < 0.05) larger TIL values for corn oil aerosol than for NaCl aerosol (Table 3)
PMID:34038318 · one of two readings recorded this
Total inward leakage (TIL), geometric mean, NaCl vs corn oil aerosol
no effect, n = 16
In the case of full-facepiece respirators, TIL for NaCl aerosol was larger than for corn oil aerosol but not statistically significant
PMID:34038318 · one of two readings recorded this
Total inward leakage (TIL), geometric mean, NaCl vs corn oil aerosol
increases, p = 0.05, n = 16
both tight-fitting and loose-fitting PAPR models showed significantly (p < 0.05) larger TIL for NaCl aerosol than for corn oil aerosol
PMID:34038318 · one of two readings recorded this
AUCGIR SS 300-360 min (glucose infusion rate, primary PD)
no effect, n = 56
AUCGIR SS 300‐360 min | Geometric LS mean (SE) | 46 462 (1425) | 46 543 (1426) | 1.0 (0.03) | (0.96, 1.04) | (0.95, 1.05)
PMID:34378307 · one of two readings recorded this
AUCINS SS 300-360 min, C-peptide corrected (sensitivity analysis)
no effect, n = 56
AUCINS SS 300‐360 min | Geometric LS mean (SE) | 18 423 (494) | 18 586 (498) | 1.0 (0.02) | 0.96, 1.02
PMID:34378307 · one of two readings recorded this
AUCINS SS 300-360 min (serum insulin, primary PK)
no effect, n = 56
AUCINS SS 300‐360 min | Geometric LS mean (SE) | 19 097 (514) | 19 267 (518) | 1.0 (0.02) | 0.96, 1.03
PMID:34378307 · one of two readings recorded this
Baseline C-peptide prior to infusion
n = 56
C‐peptide, ng/mL, geometric mean (SE) | 0.99 (0.06) | 1.00 (0.06)
PMID:34378307 · one of two readings recorded this
Baseline glucose prior to infusion
n = 56
Glucose mg/dL, geometric mean (SE) | 88.5 (0.76) | 88.0 (0.69)
PMID:34378307 · one of two readings recorded this
Baseline serum insulin prior to infusion
n = 56
Insulin, pM, geometric mean (SE) | 28.6 (1.33) | 27.7 (1.39)
PMID:34378307 · one of two readings recorded this
Cmax (serum insulin, C-peptide corrected)
no effect, n = 56
Cmax (pM) | Geometric LS mean (SE) | 357 (8.96) | 362 (9.09) | 0.99 (0.02) | 0.96 (1.02)
PMID:34378307 · one of two readings recorded this
Cmax (serum insulin)
no effect, n = 56
Cmax (pM) | Geometric LS mean (SE) | 368 (9.27) | 373 (9.39) | 0.99 (0.02) | 0.96, 1.02
PMID:34378307 · one of two readings recorded this
GIRmax variability (geometric CV%)
no effect
the variability (geometric CV%) of GIRmax was still comparable between insulins (19.3% for BAX‐HI and 21.2% for NOVO‐HI)
PMID:34378307 · one of two readings recorded this
GIRmax
no effect, n = 56
GIRmax (mg/min) | Mean (SD) | 1029 (210) | 1029 (227) | — | — | —
PMID:34378307 · one of two readings recorded this
serum insulin AUC at steady state 300-360 min (PK) and glucose infusion rate AUC at steady state 300-360 min (PD), euglycaemic clamp bioequivalence
no effect
Not recorded as a finding: subject_absent
PK bioequivalence was shown between BAX‐HI and NOVO‐HI as the 90% CI of the geometric LS mean ratio for AUCINS‐SS 300‐360 min was entirely contained within the prespecified limits of 80%‐125% (Table 2).
PMID:34378307 · one of two readings recorded this
T1/2 (serum insulin, C-peptide corrected)
unclear, n = 56
T1/2 (min) | Mean (SD) | 24.0 (9.93) | 25.54 (9.07) | — | —
PMID:34378307 · one of two readings recorded this
T1/2 (serum insulin)
unclear, n = 56
T1/2 (min) | Mean (SD) | 68.2 (79.5) | 59.4 (37.5) | — | —
PMID:34378307 · one of two readings recorded this
TGIRmax (time to GIRmax)
no effect, n = 56
TGIRmax (min) | Median [range] | 301 [65‐383] | 290 [49‐388] | — | — | —
PMID:34378307 · one of two readings recorded this
Time to onset of action
no effect, n = 56
Time to onset of action (min) | Median [range] | 21.0 [5‐35] | 19.0 [5‐33] | — | — | —
PMID:34378307 · one of two readings recorded this
Tmax (serum insulin, C-peptide corrected)
unclear, n = 56
Tmax (min) | Median [range] | 240 [30‐360] | 270 [75‐360] | — | —
PMID:34378307 · one of two readings recorded this
Tmax (serum insulin)
no effect, n = 56
Tmax (min) | Median [range] | 270 [30‐360] | 270 [75‐360] | — | —
PMID:34378307 · one of two readings recorded this
CVC occlusion
decreases, n = 1672
risk ratio (RR) 0.70, 95% confidence interval (CI) 0.51 to 0.95; 10 studies; 1672 participants; low-certainty evidence
PMID:35849083 · one of two readings recorded this
CVC occlusion
no effect, p = 0.23
No clear differences were detected after testing for subgroup differences (P = 0.23)
PMID:35849083 · one of two readings recorded this
CVC-related bloodstream infection
no effect, n = 1127
RR 0.66, 95% CI 0.08 to 5.80; 3 studies; 1127 participants; very low-certainty evidence
PMID:35849083 · one of two readings recorded this
Duration of catheter patency
no effect, n = 1788
mean difference (MD) 0.44 days, 95% CI -0.10 to 0.99; 6 studies; 1788 participants; low-certainty evidence
PMID:35849083 · one of two readings recorded this
Haemorrhage
no effect, n = 1197
RR 1.54, 95% CI 0.41 to 5.74; 3 studies; 1197 participants; very low-certainty evidence
PMID:35849083 · one of two readings recorded this
Heparin-induced thrombocytopaenia
no effect, n = 443
RR 0.21, 95% CI 0.01 to 4.27; 3 studies; 443 participants; very low-certainty evidence
PMID:35849083 · one of two readings recorded this
Mortality
no effect, n = 1100
RR 0.76, 95% CI 0.44 to 1.31; 3 studies; 1100 participants; very low-certainty evidence
PMID:35849083 · one of two readings recorded this
occlusion of central venous catheters (primary outcome), pooled risk ratio, heparin versus 0.9% sodium chloride lock
RR 0.70, 95% CI 0.51 to 0.95 for occlusion with heparin versus saline
Not recorded as a finding: the comparison was against another active treatment
Overall, combined results may show fewer occlusions with heparin compared to normal saline but this is uncertain (risk ratio (RR) 0.70, 95% confidence interval (CI) 0.51 to 0.95; 10 studies; 1672 participants; low-certainty evidence).
PMID:35849083 · one of two readings recorded this
Catheter tip at T4-T5
n = 189
Group A (n = 189) | 1 (0.53%) | 184 (97.35%) | 4 (2.12%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T4-T5
n = 218
Group B (n = 218) | 2 (0.92%) | 213 (97.70%) | 3 (1.38%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T4-T5
n = 214
Group C(n = 214) | 0 (0.00%) | 210 (98.13%) | 4 (1.87%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T6-T7 (optimal position)
n = 189
Group A (n = 189) | 1 (0.53%) | 184 (97.35%) | 4 (2.12%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T6-T7 (optimal position)
n = 218
Group B (n = 218) | 2 (0.92%) | 213 (97.70%) | 3 (1.38%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T6-T7 (optimal position)
n = 214
Group C(n = 214) | 0 (0.00%) | 210 (98.13%) | 4 (1.87%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T8-T9
n = 189
Group A (n = 189) | 1 (0.53%) | 184 (97.35%) | 4 (2.12%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T8-T9
n = 218
Group B (n = 218) | 2 (0.92%) | 213 (97.70%) | 3 (1.38%)
PMID:35970918 · one of two readings recorded this
Catheter tip at T8-T9
n = 214
Group C(n = 214) | 0 (0.00%) | 210 (98.13%) | 4 (1.87%)
PMID:35970918 · one of two readings recorded this
derived rate of stable intracavitary ECG, occurrence rate of characteristic P wave, and time used for catheter tip localization, with 0.9%, 5.45% and 10% sodium chloride as ECG conduction medium
increases
Not recorded as a finding: this platform holds no node for the endpoint
The derived rate of stable intracavitary ECG was significantly higher in the group B (χ2 = 4.31, P < 0.05) and group C (χ2 = 7.27, P < 0.05) than in the group A.
PMID:35970918 · one of two readings recorded this
Derived rate of stable intracavitary ECG
n = 213
Group A (n = 213) | 200 (93.90%) | 189 (88.73%)
PMID:35970918 · one of two readings recorded this
Derived rate of stable intracavitary ECG
increases, n = 225
Group B (n = 225) | 220 (97.78%)* | 218 (96.89%)*
PMID:35970918 · one of two readings recorded this
Derived rate of stable intracavitary ECG
increases, p = 0.05
significantly higher in the group B (χ2 = 4.31, P < 0.05) and group C (χ2 = 7.27, P < 0.05) than in the group A
PMID:35970918 · one of two readings recorded this
Derived rate of stable intracavitary ECG
no effect, p = 0.05
There was no significant difference in the derived rate of stable intracavitary ECG between the group B and group C (χ2 = 0.46, P > 0.05)
PMID:35970918 · one of two readings recorded this
Derived rate of stable intracavitary ECG
increases, n = 219
Group C (n = 219) | 216 (98.63%)* | 214(97.72%)*
PMID:35970918 · one of two readings recorded this
Derived rate of stable intracavitary ECG
increases, p = 0.05
significantly higher in the group B (χ2 = 4.31, P < 0.05) and group C (χ2 = 7.27, P < 0.05) than in the group A
PMID:35970918 · one of two readings recorded this
Derived rate of stable intracavitary ECG
modulates, p = 0.05
There were significant differences in the derived rate of stable intracavitary ECG among the three groups (χ2 = 8.38, P < 0.05)
PMID:35970918 · one of two readings recorded this
Occurrence rate of characteristic P wave
n = 213
Group A (n = 213) | 200 (93.90%) | 189 (88.73%)
PMID:35970918 · one of two readings recorded this
Occurrence rate of characteristic P wave
increases, n = 225
Group B (n = 225) | 220 (97.78%)* | 218 (96.89%)*
PMID:35970918 · one of two readings recorded this
Occurrence rate of characteristic P wave
increases, p = 0.001
significantly higher in the group B (χ2 = 11.60, P < 0.001) and group C (χ2 = 15.01, P < 0.001) than in the group A
PMID:35970918 · one of two readings recorded this
Occurrence rate of characteristic P wave
no effect, p = 0.05
There was no significant difference in the occurrence rate of characteristic P wave between the group B and group C (χ2 = 0.29, P > 0.05)
PMID:35970918 · one of two readings recorded this
Occurrence rate of characteristic P wave
increases, n = 219
Group C (n = 219) | 216 (98.63%)* | 214(97.72%)*
PMID:35970918 · one of two readings recorded this
Occurrence rate of characteristic P wave
increases, p = 0.001
significantly higher in the group B (χ2 = 11.60, P < 0.001) and group C (χ2 = 15.01, P < 0.001) than in the group A
PMID:35970918 · one of two readings recorded this
Occurrence rate of characteristic P wave
modulates, p = 0.001
There were significant differences in the occurrence rate of characteristic P wave among the three groups (χ2 = 19.06, P < 0.001)
PMID:35970918 · one of two readings recorded this
Optimal position rate of catheter tip
no effect, p = 0.05
There was not significantly different in the optimal position rate of catheter tip among the three groups (χ2 = 2.23, P > 0.05)
PMID:35970918 · one of two readings recorded this
Time used for catheter tip localization
decreases, p = 0.001
significantly shorter in the group B (P < 0.001) and group C (P < 0.001) than in the group A
PMID:35970918 · one of two readings recorded this
Time used for catheter tip localization
no effect, p = 0.63
There was no sgnificant difference in the time used for catheter tip localization between group B anf group C (P = 0.63)
PMID:35970918 · one of two readings recorded this
Time used for catheter tip localization
decreases, p = 0.001
significantly shorter in the group B (P < 0.001) and group C (P < 0.001) than in the group A
PMID:35970918 · one of two readings recorded this
Time used for catheter tip localization
decreases
(69.37 ± 19.99) seconds in group A, (49.73 ± 8.15) seconds in group B and (48.27 ± 8.61) seconds in group C
PMID:35970918 · one of two readings recorded this
Time used for catheter tip localization
modulates, p = 0.001
There were significant differences in the time used for catheter tip localization among the three groups (F = 35.04, P < 0.001)
PMID:35970918 · one of two readings recorded this
30-day AHF rehospitalization
no effect, p = 0.247, n = 50
30‐day AHF rehospitalization, n (%) | 2 (4) | 0 (0) | 2 (8) | 0.247
PMID:40455066 · one of two readings recorded this
Absolute distal Na+ reabsorption
no effect, p = 0.11, n = 50
16.5 ± 7.9% vs. 13.3 ± 8.6%, p = 0.11
PMID:40455066 · one of two readings recorded this
Sources cited
1 paper
- Subject
- sodium chloride
- Findings
- 1
- Papers
- 1